Anticancer agent containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor

• 收藏
• 分享

专利权人:

大鵬薬品工業株式会社

发明人:

江村 智博,三田 明

申请号：

JP2007500529

公开号：

JP5576591B2

申请日:

2006.01.25

申请国别(地区):

JP

年份:

2014

代理人:

摘要：

A cancer therapeutic drug enhanced efficacy and safety is provided. The cancer therapeutic drug, which is a composition containing ±,±,±-trifluorothymidine (FTD) and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride in a molar ratio of 1 : 0.5, and which is orally administered to a patient in need thereof at a dose, as a dose of FTD, of 20 to 80 mg/m 2 /day twice daily to four times daily.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/